NTH — Naturhouse Health SA Income Statement
0.000.00%
- €103.71m
- €79.29m
- €50.41m
- 84
- 75
- 77
- 95
Annual income statement for Naturhouse Health SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 81.7 | 55.1 | 57.6 | 52.4 | 50.4 |
Cost of Revenue | |||||
Gross Profit | 57.8 | 39.2 | 41.3 | 37.5 | 36.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 62.5 | 41.9 | 40.3 | 39.5 | 34.1 |
Operating Profit | 19.2 | 13.2 | 17.3 | 12.9 | 16.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 19.2 | 13.5 | 18.2 | 13.1 | 15.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13.2 | 9.39 | 13.4 | 9.62 | 11.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 13.3 | 9.38 | 13.4 | 9.63 | 11.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 13.3 | 9.38 | 13.4 | 9.63 | 11.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.215 | 0.17 | 0.225 | 0.16 | 0.189 |
Dividends per Share |